Discovery of pyrazolone spirocyclohexadienone derivatives with potent antitumor activity.
Clicks: 422
ID: 69953
2020
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
30.0
/100
422 views
48 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #7 of 246 articles by views in Bioorganic & medicinal chemistry letters
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 246 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Starting from easy accessible pyrazoletetrahydropyran acetals, a series of new pyrazolone spirocyclohexadienone derivatives were synthesized and assayed for antitumor activity. Compound 10s was identified to possess good antitumor activity. It could induce MDA-MB-231 cancer cell apoptosis in a concentration dependent manner and arrest the cell cycle progression mainly at the G1 phase.
| Reference Key |
wang2020discoverybioorganic
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Wang, Lei;Yang, Zixuan;Ni, Tianyu;Shi, Wencai;Guo, Yunbo;Li, Keliang;Shi, Anzhe;Wu, Shanchao;Sheng, Chunquan; |
| Journal | Bioorganic & medicinal chemistry letters |
| Year | 2020 |
| DOI |
S0960-894X(19)30612-2
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.